Arcturus Therapeutics Holdings Inc. counts several prominent institutional asset managers and financial funds among its largest shareholders. Major institutional stakeholders include prominent firms like Federated Hermes and ARK Investment Management, alongside various healthcare-focused mutual funds, venture capital entities, and corporate insiders who hold substantial blocks of common stock supporting its clinical-stage messenger RNA medicines pipeline.